Gadopentetic acid belongs to the class of drugs known as contrast agents. It enhances the image contrast of the internal body structures and improves the visibility due to the increase in their signal and intensity when placed in strong magnetic fields and radio waves used in MRI scanners.
In Depth Information on Magnilek Injection
Expert advice for Magnilek Injection
Gadopentetic acid must be administered in the aseptic condition to avoid infection.
Immediately inform your physician of any suspected allergic reaction after injection. Contrasting materials tend to have late onset of reactions.
Inform your doctor prior to injection if you have history of implantation of artificial pacemaker in heart or any other metal implants or clips in the blood vessels.
Inform your doctor of history of kidney disease, low blood pressure, fits (epilepsy) or other allergic respiratory conditions such as asthma.
Tell your doctor if you are pregnant, planning to get pregnant or breastfeeding.
Do not administered if allergic to gadopentetic acid or to any other such diagnostic contrasting agents.
Do not take if suffering from kidney disease.
Do not give to Children below 2 years of age.
Magnilek Injection related warnings
Special precautions for Magnilek Injection
Interaction with alcohol is unknown. Please consult your doctor.
Unknown. Human and animal studies are not available. Please consult your doctor.
Magnilek Injection is safe to use during lactation.
Human studies have shown that either the drug does not pass into the breastmilk in significant amount or is not expected to cause toxicity to the baby.
Magnilek Injection does not usually affect your ability to drive.
There is limited information available on the use of Magnilek Injection in patients with kidney disease. Please consult your doctor.
There is limited information available on the use of Magnilek Injection in patients with liver disease. Please consult your doctor.